Author

Subhendu Karmakar

Hebrew University of JerusalemORCID 0000-0002-4840-3015Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Dan GibsoniD· 1 shared Elisheva E. HeilbruniD· 1 shared Esther SterniD· 1 shared Hadar Golan-BermaniD· 1 shared Hiba HassanainiD· 1 shared Marina Frušić‐ZlotkiniD· 1 shared Ofer Chen· 1 shared Ori WaldiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Dan GibsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Novel Cisplatin-Based Prodrug Inhibits Lysine Deacetylases, Suppresses Nucleotide Excision Repair, and Overcomes Resistance

Ya’ara Negev-Korem, Esther Stern, Hadar Golan-Berman, Elisheva E. Heilbrun, Subhendu Karmakar, Yoram Soroka, Marina Frušić‐Zlotkin, Ofer Chen, Hiba Hassanain, Ori Wald, Dan Gibson, Ron Kohen, Sheera Adar

This study develops a novel cisplatin-based prodrug that inhibits lysine deacetylases and suppresses nucleotide excision repair, enhancing cisplatin's cytotoxicity and overcoming resistance.

bioRxiv · Oct 30, 2024 · PreprintMolecular Biology